Home » Topics » Regulatory

Regulatory
RSS

Supplemental NDA filed for Novantrone in U.S.

May 17, 1996

UNAIDS initiates clinical program to evaluate Advantage 24 in STD transmission

May 17, 1996

Advisory committee refuses to recommend Coreg approval for CHF

May 10, 1996

Zynaxis to develop Zyn-Linker form of paclitaxel for restenosis Rx

May 10, 1996

Napp introduces novel diltiazem formulation in U.K.

May 10, 1996

New pediatric approval for Zofran in U.K.

May 10, 1996

Saquinavir combinations under clinical evaluation

May 10, 1996

Supplemental NDA filing for Abelcet

May 10, 1996

SKB's intranasal mupirocin now available in U.S.

May 10, 1996

Avita effective for acne, less irritating

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 7, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...